Home » Newsletters » BioWorld

BioWorld

April 7, 1994

View Archived Issues

IDUN LICENSES BCL-X GENE

ANERGEN'S MYASTHENIA GRAVIS PROGRAM MOVES FORWARD

DIAGNON PLANS CANCER-FOCUSED CORPORATION

ONCOGENE GETS BROAD PATENT

SMITHKLINE LICENSES CORLOPAM RIGHTS TO NEUREX

GERMANY, ITALY BAR SALESOF DDI DRUG

IMCLONE GETS CRC CANCER VACCINE RIGHTS

METASYN COMPLETES $4M PRIVATE PLACEMENT

TOP CLOT BUSTER GRADUATES FROM HEART TO LIMBS TO BRAIN

NEW THERAPY IMPROVES GENE EXPRESSION

ANGRY SHAREHOLDERS PROPOSE CHANGES AT SCIOS NOVA

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
Nankai University and Accendatech present new majusculamide D derivatives
BioWorld Science
Scientists from Nankai University Tianjin and Accendatech Technology Co. Ltd. have identified a majusculamide D derivative found to be useful for the treatment of...